Come join us (virtually) next month for Gen Epi training!

Really enjoying this double conference IGES and ASHG trip so far! Come to poster 8006 at 2.30 to hear about how where we carry fat tissue influences our risk of cancer! #ASHG2024

✨#PhD opportunity with myself, @janemasoli and @jack_bowdenjack We will use #genetics to study how #cardiovascular risk factors vary with age, to improve mechanistic understand and clinical risk prediction🧬📈 Funded for 3.5 years! Deadline 3rd December @UniofExeter #ASHG24

We are re-advertising for an exciting 3-yr postdoc post at @imperialcollege using molecular #epidemiology to understand adiposity-driven pancreatic #cancer. Competitive salary and hybrid working options. Deadline 4/11. Email if interested! Pls retweet🙏 https://t.co/a9lkof1DX3

Interested in combining genetic epidemiology with other methods to identify modifiable causes of disease? If so a research fellow post with @mrc_ieu with @explodecomputer and me now available

If you have access to myeloma samples/data get in touch - we’d like to expand these analyses! #EpiTwitter

We have an exciting 3-yr postdoc position at @imperialcollege using molecular #epidemiology to understand adiposity-driven pancreatic #cancer. Possibility of hybrid working. Deadline 24/07 @Mattias31 @r_martin_ @Karl_SmithByrne @EmmaEVincent Pls retweet🙏 https://t.co/GXUhF1j6Rm

1/4 Excited to share our latest preprint where we used observational and Mendelian randomization methods to explore the role of metabolites as intermediates between adiposity and endometrial cancer using data from UK Biobank (@uk_biobank).

We are seeking a mol/genetic epidemiologist or bioinformatician to work at @mrc_ieu in Bristol, UK. Please get in touch if you are interested! #datascience #Bioinformatics

Really pleased to see our paper published in @eBioMedicine this week. We found that weight loss in people recently diagnosed with type 2 diabetes altered levels of cancer-related proteins in blood🩸. https://t.co/HBXwcHq1AY

Overpublishing puts enormous stress on students and PIs. And brings tons of money to publishers in STEM. A new study shows that the number of papers is increasing FASTER than the number of #PhD graduates. It’s an amazing work with very useful statistics. Huge kudos to the

Big new article from me in @PLOSBiology on the past, present and future of science publishing. 6n 🧵 on what I try to do here. (RTs appreciated). 1/n https://t.co/QSVrHMWZEz

Do you consider doing a PhD in statistical human genetics in a wonderful location? My lab [ https://t.co/F4hvsX9ygI] has open position(s) to explore human interactions, region-specific effects, evolutionary optimal transcript levels by developing advanced causal inference methods

We have a new short preprint up examining two commonly used non-linear Mendelian randomisation approaches using negative controls in the wake of recent concerns about their performance

Delighted to see our work on the metabolic features of genetic liability to type 2 diabetes and coronary artery disease published in @eBioMedicine today! @joshuaa_bell @emmylooroll @caroline_bull @ECSanderson @mendel_random @mvholmes https://t.co/6cSlFrVRhI

Our data note describing the inflammation proteomics dataset measured by @OlinkProteomics in 9000 @CO90s participants is now out in @WellcomeOpenRes https://t.co/EclETdfD9X 1/3

New pre-print available: "Violation of the constant genetic effect assumption can result in biased estimates for non-linear Mendelian randomization" available at https://t.co/GQ3NC6itwE. An update that no scientist ever wants to give. Thread follows:

How many of you know what Cruella Braverman's Public Order Bill contains? It's frankly unbelievable: legislation you might expect in Russia, Iran or Egypt. Here's a summary from my column today:

Super excited to say that our new paper is out on medRxiv! We apply and discuss the use of Mendelian randomization to estimate the causal role of the gut microbiome in colorectal cancer. #Mendelianrandomization #colorectal #cancer